IMTX
Immatics N.V. Ordinary Shares
Biological Products, (No Diagnostic Substances)
Best Biotech Stocks 2026 →
IMTX Stock Analysis: Buy, Sell, or Hold?
$6.37
-0.32 (-4.78%)
âŧ
5d:
+3.07%
30d:
-9.0%
90d:
-32.52%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (77%)
Quality Score
46/100
Position
SLIGHTLY LOW
30-Day Fair Range
$6.71 â $7.50
Position: SLIGHTLY LOW
Forward P/E & Valuation
-3.4x
Next 12M consensus est.
Wall Street Target
$16.40
+145.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$6.09 / $7.52
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: IMTX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When IMTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: IMTX is currently trading at $6.37, which is considered slightly low relative to its 30-day fair value range of $6.71 to $7.50.
Technical Outlook: Technically, IMTX is in a strong downtrend. Immediate support is located at $6.09, while resistance sits at $7.51. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $16.40 (+145.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMTX is in a strong downtrend. Immediate support is located at $6.09, while resistance sits at $7.51. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $16.40 (+145.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$6.71 -
$7.50
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Trading Range & Key Levels
30-Day Trading Range
$6.71 -
$7.50
Current vs Trading Range
SLIGHTLY LOW
Support Level
$6.09
Resistance Level
$7.52
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.8%)
- BULLISH: Trading 145.1% below Wall St target ($16.40)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-3.35
Wall Street Target
$16.40
(+145.1%)
Revenue Growth (YoY)
93.0%
Share IMTX Analysis
Share this live IMTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IMTX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
One bullish StockTwits message expresses optimism about $IMTX's future price growth, with no recent news articles available.
Key Retail Themes:
Buy the dip
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:59 PM ET
Data refreshes hourly during market hours. Next update: 2:59 PM
Data refreshes hourly during market hours. Next update: 2:59 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
DNTH
Dianthus Therapeutics InâĻ |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IMTX Research Pages
